Literature DB >> 8813950

HLA antigen expression in enteropathy associated T cell lymphoma.

M Ashton-Key1, N Singh, L X Pan, M E Smith.   

Abstract

AIMS: To investigate the occurrence of abnormal patterns of HLA-ABC and HLA-DR expression in enteropathy associated T cell lymphoma and to relate such abnormalities to the Epstein Barr virus (EBV) status of the tumours.
METHODS: Eleven enteropathy associated T cell lymphomas were immunostained with HC10 (HLA-ABC heavy chain) and TAL 1B5 (HLA-DR alpha chain) monoclonal antibodies and polyclonal anti-beta 2 microglobulin (beta 2m, the HLA-ABC light chain) antibodies. In situ hybridisation for EBV using EBER probes was performed on all cases.
RESULTS: Tumour cells of two of 11 patients were EBER positive. One of these showed partial, and the other, complete loss of beta 2m. HLA-DR expression was undetectable in both patients. Of the remaining nine EBER negative tumours, two were HLA-ABC heavy chain negative or showed only occasional positive cells and five of nine showed partial or complete loss of the HLA-ABC light chain, beta 2m. Seven of the nine cases were either negative for HLA-DR or showed weak expression in a proportion of tumour cells.
CONCLUSIONS: These data show that low or absent HLA-ABC and HLA-DR antigen expression occurs commonly in enteropathy associated T cell lymphoma. These abnormal patterns of HLA expression may be associated with escape from immune attack which, in a minority of patients, could be directed against EBV antigens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813950      PMCID: PMC500566          DOI: 10.1136/jcp.49.7.545

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.

Authors:  R A Jones; C S Scott; F E Katz; J A Child
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

2.  Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes.

Authors:  K Nilsson; P E Evrin; K I Welsh
Journal:  Transplant Rev       Date:  1974

3.  Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL).

Authors:  L Pan; T C Diss; H Peng; Q Lu; A C Wotherspoon; J A Thomas; P G Isaacson
Journal:  J Pathol       Date:  1993-06       Impact factor: 7.996

4.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

5.  Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.

Authors:  M E Smith; S G Marsh; J G Bodmer; K Gelsthorpe; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.

Authors:  C Cordon-Cardo; Z Fuks; M Drobnjak; C Moreno; L Eisenbach; M Feldman
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

7.  Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.

Authors:  L J Medeiros; A B Gelb; K Wolfson; R Doggett; B McGregor; R S Cox; S J Horning; R A Warnke
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

8.  Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

Authors:  A M Krensky; C S Reiss; J W Mier; J L Strominger; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

9.  Malignant histiocytosis of the intestine. Its relationship to malabsorption and ulcerative jejunitis.

Authors:  P Isaacson; D H Wright
Journal:  Hum Pathol       Date:  1978-11       Impact factor: 3.466

10.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells.

Authors:  H S Ko; S M Fu; R J Winchester; D T Yu; H G Kunkel
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.